Skip to content

The effect of 56-hole perfusion catheter on silent cerebral embolism during ablation of atrial fibrillation: a prospective study

The effect of 56-hole perfusion catheter on silent cerebral embolism during ablation of atrial fibrillation: a prospective study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046026
Enrollment
Unknown
Registered
2021-05-02
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atial fibrillation

Interventions

Group A:Ablation with SF catheter and 45W
Group B:Ablation with SF catheter and 35W
Group C:Ablation with ST catheter and 35W

Sponsors

Shanghai First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 30 to 80 years; 2. Patients with recurrent paroxysmal atrial fibrillation, which was confirmed by recorded electrocardiograms of atrial fibrillation; 3. Agree to accept radiofrequency catheter ablation; 4. Patients are willing to sign informed consent to participate in this study; 5. Patients can complete the study according to the requirements of the research plan, including ablation and follow-up.

Exclusion criteria

Exclusion criteria: 1. Atrial fibrillation with reversible causes (such as cardiac surgery, pulmonary embolism, untreated hyperthyroidism and so on); 2. Previous surgical or interventional treatment for atrial fibrillation (including maze surgery, catheter ablation, left atrial appendage occlusion, etc); 3. Severe heart diseases (such as severe mitral stenosis or regurgitation, severe aortic stenosi0s or regurgitation, hypertrophic obstructive cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, etc; 4. Thrombus or tumor in the atrium; 5. Patients with contraindications to heparin or oral anticoagulants; 6. The creatinine clearance rate was less than 30ml / min; 7. Pregnant women; 8. The patient had MRI contraindications for implanted non-anti-MRI pacemaker or other metal devices; 9. Previous cerebral infarction or transient ischemic attack.

Design outcomes

Primary

MeasureTime frame
Silent cerebral embolism;

Secondary

MeasureTime frame
Perioperative complications;Procedure duration;X-ray time;Ablation time;

Countries

China

Contacts

Public ContactWei Yong

Shanghai First People's Hospital

weiyong202@qq.com+86 18918288889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026